Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

The document is a detailed medical reference on skin and genetic disorders.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The journal covered various dermatology topics, including treatments, disease management, and research findings.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

A woman was allergic to quinine in her anti-hair loss lotion.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Skin problems are very common in people with end-stage kidney disease.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.